Afrezza is a miracle drug! It should be selling itself ! By this time prescriptions should be over 20,000 a week ! Whats going on ! 274 new prescriptions for week ending 30 Nov. 18 ! Are sales force even trying to sell ! Or are sale force just get there fat paychecks to drive around in all them fancy cars !!!
Its a great product, for sure. Reps should be very proud to be selling it. And doctors that don't use it more often, need to get educated better on what this product can do.
Drug will never become mainstream till spirometer testing and lung safety long term is established. Get over it our physicians clearly have.
Think you are looking into this too much. There are enough people that benefit from this product, and show profit. It doesn't have to be the best product in a huge market.
Not really growth hormone in lungs is very legitimate concern for providers. Add a ton of hassle factors and the product is a niche at best.
Hey, Afrezza scripts hit 726 this week, just slightly behind the 21K scripts for Humalin and 12.3K scripts for Novolog. Yes, just four years after launching with Sanofi and having three different MNKD sales forces we have finally cracked 2% market share. Lilly and Novo must be shitting themselves.
Dense? What does it compete against? Oh that other inhaled insulin that doesn’t exist anymore? You’re right Afrezza rules 100% market share in inhaled insulin class. Go Afrezza!
Yes they do, and long term success will be there. You just don't know shit about sales or pharmaceuticals.
i think you are the one that doesn’t know shit. 5 years and the product isn’t making jack shit and the company is a dumpster dive
Really! This drug is competing against itself? Well then it’s doing a pretty poor job of it. Afrezza is a bottomless pit that Mannkind keeps throwing money in to! Glaxo knew when to walk away from exubera, Sanofi knew when to walk away from Afrezza, all the other Pharma companies working on an inhaled insulin were smart enough to walk away. Mannkind is only hanging on to line the pockets of their corporate executives.
Glaxo, or GSK, never had Exubera, they had Tanzeum. I think it may have been Pfizer for the other inhaled insulin
You are definitely uneducated and do not have a medical background to make a statement like this. If you did you would run from this product. I am a HCP and would never prescribe Afrezza to my patients. Read the studies....I mean REALLY read them and think. Why in God’s name would I prescribe an inhaler growth hormone that’s not native to lung tissue?? Especially when most of my adult type I’s have been injecting their whole life and the Type II’s are already injecting GLP-I agonists way before starting insulin. If the Type II’s move on to insulin then they are already compromised and most likely leading an unhealthy lifestyle. You honestly think I’m going to add more risks and prescribe Afrezza to inhale into the lungs of a patient whose immune system is already compromised from diabetes? I’d tell my patients to suck it up and inject themselves with a needle that is hardly felt because it’s so small these days. After the first injection they see what I’m talking about. Keep working on that educating...and I don’t mean the HCPs. Trust me, we are plenty educated and it’s offensive when someone with a business degree comes in acting like “we need to be educated”. If you and your leadership had any bit of medical training or background you would have run from the company a long time ago!! Best of luck to ya!
